BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Liver cancer AND ACSL3, PRO2194, 2181, ENSG00000123983, O95573, FACL3, ACS3 AND Treatment
8 results:

  • 1. Pan-cancer analysis identifies LPCATs family as a prognostic biomarker and validation of LPCAT4/WNT/β-catenin/c-JUN/acsl3 in hepatocellular carcinoma.
    Lu Y; Liang H; Li X; Chen H; Yang C
    Aging (Albany NY); 2023 May; 15(11):4699-4713. PubMed ID: 37294538
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Identification of ferroptosis and drug resistance related hub genes to predict the prognosis in Hepatocellular Carcinoma.
    Li C; Cui X; Li Y; Guo D; He S
    Sci Rep; 2023 May; 13(1):8681. PubMed ID: 37248280
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Site-Specific and Targeted Therapy Based on Molecular Profiling by Next-Generation Sequencing for cancer of Unknown Primary Site: A Nonrandomized Phase 2 Clinical Trial.
    Hayashi H; Takiguchi Y; Minami H; Akiyoshi K; Segawa Y; Ueda H; Iwamoto Y; Kondoh C; Matsumoto K; Takahashi S; Yasui H; Sawa T; Onozawa Y; Chiba Y; Togashi Y; Fujita Y; Sakai K; Tomida S; Nishio K; Nakagawa K
    JAMA Oncol; 2020 Dec; 6(12):1931-1938. PubMed ID: 33057591
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Dynamic contrast-enhanced MRI coupled with a subtraction technique is useful for treatment response evaluation of malignant melanoma hepatic metastasis.
    Lee M; Baek SE; Moon J; Roh YH; Lim JS; Park MS; Kim MJ; Kim H
    Oncotarget; 2016 Jun; 7(25):38513-38522. PubMed ID: 27229529
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Transarterial chemoembolization in unresectable hepatocellular carcinoma--assessing the factors affecting the survival: An audit from a tertiary care center in northern India.
    Agarwal A; Yadav AK; Kumar A; Gupta S; Panwala HK; Redhu N; Hariprasad S; Ranjan P; Arora A; Gupta A
    Indian J Gastroenterol; 2015 Mar; 34(2):117-26. PubMed ID: 25937484
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Long chain acyl-CoA synthetase-3 is a molecular target for peroxisome proliferator-activated receptor delta in HepG2 hepatoma cells.
    Cao A; Li H; Zhou Y; Wu M; Liu J
    J Biol Chem; 2010 May; 285(22):16664-74. PubMed ID: 20308079
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Long chain acyl-CoA synthetase 3-mediated phosphatidylcholine synthesis is required for assembly of very low density lipoproteins in human hepatoma Huh7 cells.
    Yao H; Ye J
    J Biol Chem; 2008 Jan; 283(2):849-54. PubMed ID: 18003621
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Factors predicting for response, time to treatment failure, and survival in women with metastatic breast cancer treated with DAVTH: a prospective Eastern Cooperative Oncology Group study.
    Falkson G; Gelman R; Falkson CI; Glick J; Harris J
    J Clin Oncol; 1991 Dec; 9(12):2153-61. PubMed ID: 1960558
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.